The pharmaceutical industry relies on a foundation of impeccably pure chemical compounds to develop safe and effective medications. At NINGBO INNO PHARMCHEM CO.,LTD., we recognize that the quality of the final Active Pharmaceutical Ingredient (API) is directly proportional to the quality of the intermediates used in its creation. This principle is especially true when it comes to complex antibiotics like Tedizolid Phosphate, where precision in pharmaceutical intermediate synthesis is non-negotiable.

Our Benzyl (3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)Pyridin-3-yl)Phenyl)Carbamate (CAS 1220910-89-3) exemplifies this commitment to purity. As a crucial building block for Tedizolid Phosphate, this white to off-white powder intermediate is manufactured under strict quality control measures. The certifications it holds – GMP, ISO 9001, and FDA – are not just badges, but guarantees of its suitability for sensitive tedizolid phosphate manufacturing processes. This dedication ensures that every batch meets the highest standards required for drug development processes.

The careful selection and sourcing of chemical synthesis intermediates are vital for preventing impurities that could compromise the safety or efficacy of the final drug. Our fluoro-pyridinyl phenyl carbamate is a testament to this, providing a reliable and consistent raw material. Manufacturers looking to optimize their supply chain and ensure product integrity will find our comprehensive approach to quality assurance invaluable. We are committed to providing intermediates that not only meet but exceed industry expectations for purity and performance.

Understanding the detailed specifications of each intermediate, such as its melting point and stable physical form, is part of our service to the scientific community. By offering intermediates like CAS 1220910-89-3, NINGBO INNO PHARMCHEM CO.,LTD. aims to support the advancement of pharmaceutical research and the efficient production of critical medicines, thereby contributing to global health outcomes through reliable pharmaceutical intermediate needs.